Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 70,000
+900 (1.30%)
Jul 7, 2026, 11:05 AM KST
KRX:185750 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, KRX:185750 stock has a consensus rating of "Buy" and an average price target of ₩121,000. The average 1-year stock price forecast is 72.86% higher than the current stock price, while the lowest is ₩100,000 (+42.86%) and the highest is ₩155,000 (+121.43%).
Price Target: ₩121,000 (+72.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KRX:185750 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 2 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 5 |
Financial Forecast
Revenue This Year
1.91T
from 1.69T
Increased by 12.70%
Revenue Next Year
1.98T
from 1.91T
Increased by 3.64%
EPS This Year
5.14K
from 6.54K
Decreased by -21.49%
EPS Next Year
6.33K
from 5.14K
Increased by 23.21%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9T | ||
| Avg | 1.9T | ||
| Low | 1.9T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.9% | ||
| Avg | 12.7% | ||
| Low | 12.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5,146.00 | ||
| Avg | 5,137.50 | ||
| Low | 5,129.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -21.4% | ||
| Avg | -21.5% | ||
| Low | -21.6% |